Esophageal Cancer Clinical Trial

Retrospective Review of Esophageal Cancer at MSKCC

Summary

Residual tumor at the proximal or distal margin after esophagectomy is a known prognostic factor for poor survival outcomes in patients with esophageal cancer; however, the significance of the circumferential resection margin (CRM) remains controversial. In this study, the investigators sought to evaluate the prognostic significance of the CRM in patients with esophageal cancer undergoing resection.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologically confirmed esophageal adenocarcinoma (EAC) or esophageal squamous cell carcinoma (ESCC) undergoing esophagectomy
Pathologic staged T3 tumors (pT3)

Exclusion Criteria:

Pathologic staged T0-2 (pT0-2) or T4 tumors (pT4)
Patients with histologic types other than EAC or ESCC, dysplasia or carcinoma in situ without tumor invasion,
Patients undergoing salvage esophagectomy
Evidence of distant metastatic disease
Patients with a positive proximal or distal margin

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

4000

Study ID:

NCT05706558

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York New York, 10065, United States More Info
Daniela Molena, MD
Contact
212-639-3870

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

4000

Study ID:

NCT05706558

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.